We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

August 14, 2018

HealthXL & Bayer Announce Partnership

Announcements/News
Maeve Lyons

Bayer becomes active member of HealthXL to foster evidence based digital health.

Bayer is expanding its global open innovation approach with HealthXL, and is supporting evidence based digital health startups. The partnership with HealthXL is one aspect of Bayer’s external engagement in the digital space:

“We see ourselves as an active partner in the global ecosystem of digital innovation, open for new ideas and creative approaches." Eugene Borukhovich, Head of Digital Health at Bayer

For the past five years, Eugene Borukhovich has been an integral member of HealthXL and advisor to the community.

“There still continues to be a lot of noise in digital health and health technology. HealthXL is a good partner to move forward with to deliver upon our mission Science For A Better Life.”

Since 2012 Bayer supports Digital Health companies and passionate entrepreneurs through its #G4A programs which highlight the company’s commitment to collaboration with innovators and startups. Bayer recently launched its first US program focused on developing self-care innovation partnerships: G4A Generator.

“Bayer has been a leader in health technology for many years. We are delighted to expand our work with Eugene and the Bayer team as we progress our mutual objectives of identifying and bringing evidence based health technology into the global marketplace" Martin Kelly, CEO HealthXL

Next steps

Bayer will participate in HealthXL next Global Gathering, which is being hosted at the National Robotics Engineering Center part of Carnegie Mellon University in Pittsburgh, PA 8 February. Pittsburgh is one of the leading innovation and tech hubs in the US, the event will incorporate healthcare experts from UPMC, Philips and CMU and discuss topics such as Precision Medicine & Genomics and Big Data & AI - 'Hype v Reality'. More details here

About Bayer

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2016, the Group employed around 99,600 people and had sales of EUR 34.9 billion. Capital expenditures amounted to EUR 2.2 billion, R&D expenses to EUR 4.4 billion. For more information, go to www.bayer.com

About HealthXL

HealthXL builds global communities who want to improve health outcomes. Our platform connects innovators through evidence driven insights from world leading healthcare executives, clinicians and technologies. HealthXL works with 40+ leading global companies and health systems to provide insights, evidence and expertise on digital health and health technology.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Do Accelerators Work to Nurture Innovation?

18th January @ 11:00am ET
Please bear with us. This meeting is under construction, details will follow shortly.
Featuring
Sophie Park
Sophie Park
Managing Director, Bayer G4A Digital Health
Jochen Hurlebaus
Jochen Hurlebaus
Head of Innovation & IP, Roche Diagnostics
Featuring
Sophie Park
Sophie Park
Managing Director, Bayer G4A Digital Health
Jochen Hurlebaus
Jochen Hurlebaus
Head of Innovation & IP, Roche Diagnostics

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Health Meeting
12th December @ 11:00am ET

Masterclass: Year-to-Date Review: A Rollercoaster Year for DTx

DTx has faced numerous challenges in the past year.

Dr. Krutika Gohil
Featuring
Dr. Krutika Gohil
Director Digital Medicine & DTx Outcomes - ZS
Digital Health Meeting
4th January @ 11:00am ET

How to Scale Partnerships Between Lifesciences and Digital Health Companies?

Pharma companies have identified technology as an opportunity to deliver more value to their patients and clinicians and differentiate from other competitors.

Piotr Sokolowski
Featuring
Piotr Sokolowski
Head of Strategy, MedTech Solutions at S3 Connected Health
Digital Health Meeting
9th January @ 11:00am ET

Masterclass: How Exactly Does the Employer Pathway as a Business Model Work?

Large, self-insured employers are the main buyers of digital health solutions for employee benefits. For many digital health solutions, it has proven to be a good starting point to acquire customers, observe the product in the real world, and establish a revenue stream. 


Featuring
Digital Health Meeting
11th January @ 11:00am ET

Masterclass: VC Funding For Digital Health: Future Outlook 2024

2020 was a period of optimism in the investment market, with companies receiving large amounts of capital and investors expecting returns.

Featuring

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.